The present application relates to a method and apparatus for delivering an aerosol, nebulized liquid or solid medicine or a vapor to a patient's respiratory tract.
Medical nebulizers for generating a fine spray or nebula of a liquid medicine that can be inhaled by a patient are well known devices commonly used for the treatment of certain conditions and diseases. Nebulizers have applications in treatments for conscious, spontaneously-breathing patients and for controlled ventilated patients.
In some nebulizers, a gas and a liquid are mixed together and directed against a baffle. As a result, the liquid is aerosolized, that is, the liquid is caused to form into small particles that are suspended in the air. This aerosol of the liquid can then be inhaled into a patient's respiratory tract. One way to mix the gas and liquid together in a nebulizer is to pass a quickly moving gas over a liquid orifice tip of a tube. The negative pressure created by the flow of pressurized gas will draw the liquid out of the liquid orifice tip into the stream of gas and nebulize it.
Some of the considerations in the design and operation of nebulizers include regulation of dosages and maintenance of consistent aerosol particle size. In conventional nebulizer design, pressurized gas may entrain a liquid against a baffle on a continuous basis until the liquid in a reservoir is depleted. Continuous nebulization may result in a waste of aerosol during a patient's exhalation or during a delay between a patient's inhalation and exhalation. This effect may also complicate regulation of dosages because the amount of wasted aerosol may be difficult to quantify. Also, continuous nebulization may affect particle size and/or density. In addition, there may be excess medication lost to condensation on the nebulizer or mouthpiece during periods of non-inhalation. On the other hand, interrupted nebulization may also affect particle size and density as the nebulization is turned on and off.
A method and apparatus for delivering nebulized liquid or solid medication or vapor to a patient is disclosed.
The disclosed nebulizer design takes advantage a moving baffle concept, where the baffle is mounted to an actuator which has a constrained ability to move vertically within the nebulizer. Some known baffles may be incorporated into the top portion of the nebulizer and may require careful manual assembly in order to position the actuator within the nebulizer at a desired position in relation to the baffle. The travelling baffle design disclosed herein integrates the baffle into the actuator and may reduce the difficulties that may be experienced in manual assembly and may reduce the need for rotational orientation during assembly, thus allowing other components of the nebulizer to follow suit.
As described in greater detail below, a diaphragm includes a flexible membrane that responds to the changing pressures inside the nebulizer to drive the actuator and the baffle towards the pressured gas orifice, such that the baffle radially deflects gas injected into the nebulizer from a pressurized gas orifice outwards creating a low pressure zone over an adjacent liquid orifice. The capillary effect, along with the low pressure zone, draw the liquid from the reservoir in the nebulizer via the orifice and into the gas stream from the pressurized gas orifice. The diaphragm combines a biasing element, a latch feature to assemble the actuator with the diaphragm, an inhalation valve and an exhalation valve into a single part. The biasing element of the diaphragm is designed to provide assistance to the movement of the actuator. The amount of assistance needed from the diaphragm to move the actuator depends on a number of factors. These factors include the weight of the actuator, the upwards force created by the pressurized gas striking the baffle, any friction impeding the actuator, and any vacuum force generated by internal aerodynamics of the nebulizer.
The assistance the biasing element of the diaphragm provides to the movement of the actuator can be in one of two directions. The biasing elements can help to hold the actuator in the “normally off” condition with the biasing element being sufficiently strong enough to hold the actuator in an UP/OFF position even when pressured gas is not injected into the nebulizer through the pressured gas inlet. This biasing element is ideally responsive enough to quickly react to negative pressures generated though inhalation. Conversely, the biasing element could also be implemented to hold the actuator in the “normally on” condition when pressured gas is applied to the pressured gas inlet. The biasing element would be sufficiently weak to allow the actuator to move to the UP/OFF position when pressured gas is applied to the pressured gas inlet, yet strong enough to help the patient overcome the force imparted by the gas stream on the actuator and minimize the work needed to be done on inhalation.
In addition to the biasing member function of the diaphragm, the diaphragm includes two valves that may behave like pressure relief valves: an inner valve is a center opening valve positioned in to resist opening until the spring has collapsed and aerosol is being generated. Controlling the inhalation valve involves balancing between premature and delayed opening. Premature opening of the inhalation valve would increase the flow required to actuate, reducing the drug delivered per breath, and thereby increasing the overall drug delivery time. In an extreme situation, the nebulizer would fail to actuate and a delayed opening would make inhaling through the device more difficult since the user would need to impart more energy to sustain flow through the inhalation valve. In an extreme case, a user would not be able to generate enough vacuum to open the inhalation valve and no flow would be generated.
Also disclosed in the implementations provide herein are features such as an exhalation pathway that channels expired air out of the rear of the nebulizer, away from the patient, as well as a mode selector and methods of use. Various methods discussed herein allow for switching the nebulizer between a breath-actuated mode, where aerosol is only generated upon inhalation through the nebulizer mouthpiece, and a continuous mode, where the mode selector fixes the components of the nebulizer to continuously generate an aerosol as long as a pressurized gas is being supplied and a medicament is present in the reservoir.
Referring now to
The components of the nebulizer 10 include a bottom housing 14 having a cylindrical body. The nebulizer 10 also contains a top portion, referred to as the retainer 16, and an internal assembly, referred to as the inner housing 18. A flexible component is also included in the nebulizer 10, and is referred to as the diaphragm 20. A long, shaft-like component, referred to as the actuator 22, is also contained within the nebulizer 10. The final component is the tubular mouthpiece 12. The components of the nebulizer 10, other than the diaphragm 20, may be formed with a single piece of material by an injection molding process and assembled without the use of welding or adhesives and joined together using interference fits.
The retainer 16, actuator 22, inner housing 18, bottom hosing 14 and mouthpiece 12 may all be constructed from a plastic material such as, but not limited to, polypropylene. Any of a number of types of plastic may be used to construct these parts of the nebulizer 10. The diaphragm 20 may be constructed from, but not limited to, a flexible material such as silicone.
Referring to
The nozzle cover 34 is a tapered tubular member with openings at either end. When positioned over the pressurized gas inlet 24, the space between the nozzle cover 34 and the pressurized gas inlet 24 creates at least one passageway 36 between the radial opening created by the gap between the nozzle cover 34 and the bottom wall 32 of the bottom housing 14 and the annular opening 38 defined by the outer diameter of the nozzle end of the pressurized gas inlet 24 and the inner diameter of the nozzle cover 34. To maintain the proper size of the annular opening 38 and position of the nozzle cover 34 over the pressurized gas inlet 24, triangular ribs 40 may be included on the inside surface of the nozzle cover 34 and are designed to cooperate with a ledge 42 of the pressurized gas inlet 24, formed near the tip to locate the nozzle cover 34 concentrically and maintain the passageway opening 44 between the lower edge of the nozzle cover 34 and the bottom wall 32 of the bottom housing 14.
The lower chamber of the bottom housing 14 is preferably used as a reservoir 46 and holds a fluid for nebulizing, such as a solution containing medication. In one embodiment, the lower wall of the bottom housing 14 slopes down to the base of the pressurized gas nozzle so that gravity urges the fluid into the reservoir 46, towards of the opening 44 of the passageway 36. As shown in
Referring to
The tip of the nozzle cover 34 and tip of the pressurized gas inlet 24 may be flat surfaces. In one implementation, the pressurized gas orifice 30 is positioned in the plane of the annular orifice 38. Alternatively, the plane of the gas orifice 30 may be parallel to, and offset from, the plane of the tip of the nozzle cover. The relative heights (offsets) of the tips of the pressurized gas inlet 24 and the nozzle cover 34 may be varied to achieve the desired nebulization characteristics.
On the opposite end of the bottom housing 14 from the pressurized gas inlet 24, the inner housing 18 is removably attached to the cylindrical wall of the bottom housing 14 through the use of three (3) equidistantly separated ledges on both the bottom housing 14 and inner housing 18 to which the inner housing 18 may be loosely rotated under for a frictional fit to the bottom housing 14. Rotational orientation of the inner housing 18 relative to the bottom housing 14 may be controlled by a tab incorporated into the inner housing 18 and a corresponding flat surface on the bottom housing 14 which arrests the rotational motion of the inner housing 18 when positioned correctly. A ramp profile in the bottom housing 14 ensures the ledges on the inner housing 18 move under the ledges on the bottom housing 14 as the tab follows the ramp profile. Though this example utilizes three (3) equidistantly spaced ledges around the outer surface of the bottom housing 14 and inner housing 18, any number of these threaded features may be used to the same effect in other implementations. When assembled, the outer surface of the inner housing 18 forms an interference fit with the inner surface of the bottom housing 14 to ensure that air and aerosol is unable to leak between the two components and into the ambient environment.
The outer flange of the retainer 16 contains four (4) cut-outs 50 which snap fit with corresponding male extrusions 52 on the outer surface of the inner housing 18 to assemble the retainer 16 to the inner housing 18. Two (2) textured flats 54 are included on the outer surface of the retainer 16 that break the circular profile of the outer flange, which aid in the assembly of the inner housing 18 to the bottom housing 14 as they mate with corresponding flats 56 on the outer surface of the inner housing 18. This aids in the implementation of automated assembly as the flats 54, 56 provide features for robotic assembly systems to grasp as well as for determining orientation with vision systems and reduce the probability of human error on assembly. The flats 54, 56 on the inner housing 18 and retainer 16 also allow the parts to be bowl fed to an automated assembly. The retainer 16 is designed such that the retainer 16 may be assembled to the inner housing 18 in either of the configurations possible that allow the flats on the inner housing 18 and bottom housing 14 to be parallel to each other on assembly as the features of the retainer 16 are symmetrical. The flats 54, 56 also help to hold the rotational orientation of the retainer 16 relative to the inner housing 18 after assembly.
Referring to
When pushed through, the ridges slide into the receiving grooves on the actuator 22 and weakly hold the diaphragm 20 in place, relative to the actuator 22. The amount of interference between the actuator 22 and diaphragm 20 is an important element of the design as excessive force can cause deformation of the diaphragm 20, affecting the flow characteristics of the valves. No rotational orientation is required for the assembly of the diaphragm 20 and the actuator 22. There exists only a top-down orientation when assembling the diaphragm 20 to the actuator 22. Though only two (2) surfaces of contact 66 positioned at the end of support arms 64 extending from the central axis of the actuator 22, separated by 180 degrees around the common axis of the diaphragm 20 and the actuator 22, are used to stabilize the diaphragm 20, any number of such features could be used of various mating geometries though they are preferably equidistantly positioned around the actuator 22 to ensure the diaphragm 20 does not deform.
The diaphragm 20 and actuator 22 assembly is coaxially and slideably positioned within the nebulizer, inside the cavity created by the inner housing 18, with the coaxial body of the actuator 22 piston extending into the inner housing 18 along the longitudinal axis of the nebulizer as well as through a coaxial opening in the retainer 16 body. The closed, lower feature of the actuator 22 that extends into the cavity of the inner housing 18 defines a diverter 68 for diverting the flow of pressured gas emerging from the pressurized gas orifice 30. In one implementation, the diverter 68 has a flat, circular surface having a predetermined area. The surface is also preferably aligned parallel to the tip of the pressurized gas inlet 24 and perpendicular to the direction of flow of the pressurized gas through the pressurized gas orifice 30. Concentric alignment of the diverter 68 in relation to the pressurized gas orifice 30 is aided by a downward sloping flange 70 connected to the main actuator body with two arm protrusions 72. The downward sloping flange 70 acts as a guide and slides along the outer surface of the tapered end of the nozzle cover 34. The downward sloping flange 70 may be a short, tapered tubular feature with an opening at either end to allow pressured gas to travel unimpeded through its center, in addition to the tapered end of the nozzle cover 34. The flange 70 also helps to set a predetermined distance ‘h’ between the diverter surface and the surface of the pressurized gas orifice as the bottom of the flange 70 will contact a corresponding shoulder on the nozzle cover 34. The mouthpiece 12 is a tubular part with an ovular opening on one end for the patient to breathe through, and a cylindrical opening on the other end, that may be a 22 [mm] ISO standard fitting that is press-fit into the corresponding cylindrical tube extending from the bottom housing 14, perpendicular to the axis of assembly for all other components.
Referring again to
Referring to the embodiment of
To improve the performance of the nebulizer 10 in eliminating non-optimally size particles, the outer surface of the inner housing 18 may include an extension 86 that extends to the inner surface of the bottom housing 14 and at least part way around the outer circumference of the inner housing. The extension 86 acts to intercept oversized particles entrained in the gas flow and condense on the lower surface of the extension 86 and fall back into the reservoir 46. This also helps to decrease the number of oversized particles being inhaled through the mouthpiece. The extension also ensures ambient air that is drawn into the nebulizer takes a more circuitous route through the aerosol before it leaves the nebulizer. This may assist to limit the particle density and reduce the chance of particle growth through accidental particle collisions. As stated above, the actuator is required to move from the UP/OFF (non-nebulizing) position and the DOWN/ON (nebulizing) position for nebulization to occur. Inhalation of ambient air into the nebulizer via the mouthpiece 12 and the exhalation of expired air through the nebulizer and out to the ambient atmosphere and the resistance to this airflow are important factors which must be controlled to minimize the work required to be done by the patient during a treatment.
The biasing element 78 integrated into the diaphragm 20 assists in the movement of the actuator 22 and is configured to ensure nebulization occurs on inhalation when in breath actuated mode yet remains off when inhalation is not occurring to reduce risk of medication released to the ambient environment. Minimizing the inhalation flow required to move the actuator 22 is desirable because lowering the flow required to actuate means that nebulization of the medication may start earlier during inhalation and stop closer to the end of exhalation, thus generating more aerosol in each breath and maximizing drug output. In the diaphragm 20 of
Inhalation airflow passes through the center-opening inhalation valve 80. In this configuration the inhalation valve 80 uses a donut valve design. As stated previously, the use of an inhalation valve 80 that seals onto the actuator 22 results in assembly that requires no rotational orientation between the actuator 22 and diaphragm 20 with only a vertical orientation needing to be considered. The diaphragm 20 is pinned in place between a ring-shaped extrusion 88 (also referred to herein as an exhalation skirt) located on the retainer 16 and a sealing surface 90 on the inner housing 18. This diaphragm retention technique helps to maintain a constant resting position for the diaphragm 20, locates the diaphragm 20 concentrically within the nebulizer 10, separates the movement of the biasing element 78 from the circumferential exhalation valve 82 and isolates the exhalation flow pathway and the inhalation flow pathway. On inhalation, the exhalation flange contacts a sealing surface incorporated into the inner housing 18 and the pathway is blocked. When sufficient negative pressure has been reached, the donut-shaped inhalation valve 80 is pulled away from the sealing surface 98 of the actuator 22 and air can flow around the sealing surface 98, through the pathway created by the donut-shaped inhalation valve 80, and into the main cavity of the nebulizer 10. Openings 94 located in the retainer 16 and openings 96 in the inner housing 18 allow air to move from the nebulizer's main chamber and into and out of the nebulizer 10.
Referring to
On inhalation, the biasing element 78 of the diaphragm 20 rolls inward in response to negative pressure from within the nebulizer 10, acting on the lower surface of the diaphragm. This lowers the position of the actuator 22, bringing the diverter 68 closer to the pressured gas orifice 30 until the actuator 22 reaches the nebulizing position so that the diverter 68 it diverts the flow of the pressured gas. The negative pressure inside the nebulizer also opens the inhalation valve on the diaphragm, allowing atmospheric air to be drawn into the device to improve the delivery of fine particle mass and to maintain a low inhalation resistance to minimize the work needed to be done by the patient during inhalation. Atmospheric air is drawn into the nebulizer through openings 94 integrated into the retainer.
On exhalation, expired air moves through the nebulizer 10 and exits through the rear of the nebulizer, away from the patient, to ensure no medication is deposited on the patient's face or eyes. In one embodiment, two (2) rectangular windows 96 on the back and top of the inner housing 18 (See
An alternative embodiment of the nebulizer 10 of
Referring to
Referring again to
In another embodiment, as shown in
As with the other center-opening valves discussed previously, this design requires no rotational orientation between the actuator 222 and diaphragm 220 on assembly and only has vertical orientation requirements, such as to align with the sealing surface 298 on the actuator 222. The diaphragm 220 may be pinned in place between ring shaped extrusions 289, 288 located on the inner housing 218 and retainer 216, respectively. The configuration of the nebulizer 210 having the diaphragm 220 pinned as illustrated in
On inhalation into the nebulizer 210 of
Exhalation airflow 299 passes through vents located in the retainer 216, across the circumferential valve 282 and out of the nebulizer 210 through windows located on the retainer 216. The biasing element 278, or the spring, of the diaphragm 220 is located between the actuator latch 260, 262 and the circumferential exhalation valve 282 and is designed to have a resistance to motion that is sufficiently strong enough to hold the actuator 222 in the UP/OFF position until inhalation begins, yet responsive enough to quickly react to negative pressures generated through inhalation. The biasing element 278 may consist of flexible material arranged in a concave-down geometry of that rolls inward in response to negative pressure within the nebulizer 210, acting on the lower surface of the diaphragm 220.
In a fourth embodiment, as illustrated in
During assembly of this embodiment of nebulizer 310, the actuator 322 may be inserted through the center of the diaphragm 320 from the circumferential exhalation valve 382 side such that the inhalation valve 380 bends out of the way of the tapered positioning flange 370 of the actuator 322 and returns to its unstressed position once the flange 370 is passed. Because a single central actuator shaft, such as illustrated in prior embodiments discussed above, is not available due to the central flap valve configuration of the inhalation valve 380, the actuator 322 is configured with parallel arms 323 and will require limited rotational orientation during assembly.
Referring to
In the nebulizing position, where the diverter 368 is spaced from the gas orifice 330 and annular fluid orifice 338 at a predetermined distance to cause pressurized gas from the orifice 330 to deflect over the annular orifice 338 and draws up and aerosolizes the medicament into the pressurized gas flow, the nebulized medicament can then mix with the air drawn into the nebulizer. The air drawn into the nebulizer, now laden with aerosolized medicament, can then follow the flow path through the mouthpiece to the patient. The negative pressure inside the nebulizer during inhalation also pulls the circumferential exhalation valve 382 down onto the inner wall of the inner housing 318 forming a sealing surface and preventing inhalation airflow in the exhalation pathway. The diameter of the circumferential exhalation valve 382 on the diaphragm 320 is preferably selected to be sufficient to contact the inner surface of the inner housing 318 on inhalation with no gaps through which air could leak.
Referring to
In another embodiment, as illustrated in
As shown in
In each of the embodiments presented above, the biasing element worked to lift the actuator and provide a force opposite to the force generated through inhalation. Alternatively, a biasing element that provides a downward force on the actuator could be used. The biasing element would have a resistance to motion that is sufficiently weak enough to allow the actuator to move to the UP/OFF position when pressurized gas is applied through the pressurized gas inlet until inhalation begins, yet responsive enough to quickly react to negative pressures generated through inhalation. Unlike previous configurations, a biasing element working in the opposite direction would hold the actuator down when pressurized gas is not applied to the nebulizer. The biasing element would be comprised of a flexible material that rolls inward in response to negative pressure within the nebulizer, acting on the lower surface of the diaphragm. This solution may be advantageous as it can be used to lower the inhalation flow required to actuate the devices and maximize the duration of aerosol generation over course of a single breath. Though the different variations of diaphragm designs discussed above are presented as separate embodiments, it is to be understood that each inhalation valve, exhalation valve, and biasing element presented may be combined in any configuration of the three elements to the same effect.
The methods by which any of the above-described nebulizers may be manually set to continually nebulize a fluid present in the chamber will now be explained in greater detail. In the currently available nebulizer, the nebulizer has a dial feature that snaps into the retainer and can be rotated. When rotated in a predetermined direction, two (2) finger-like protrusions on the dial push against a ramp profile integrated into the diaphragm and push the diaphragm. This, in turn, lowers the actuator to the nebulizing position and aerosol is produced. In the preferred embodiment, the actuator and dial of the previous generation nebulizer have been merged into a single part, now referred to only as the actuator. Rotation of the actuator, rather than the dial, allows for manual switching between breath actuated and continuous nebulization. In order to accommodate a diaphragm that incorporates the inhalation valve, exhalation valve and biasing element in one part, the ramp profile was incorporated into the retainer in a flange bordering the center opening in the retainer, through which the indicating feature of the actuator protrudes.
Referring to
The height that the indicating feature of the actuator extends above the upper surface of the retainer provides a visual indication when nebulization is occurring, as well as the actuator will drop a vertical the mode the nebulizer is set to. On inhalation, distance due to the negative pressure generated inside the nebulizer. When rotated between the breath-actuated and continuous mode, the orientation of the dial ears will change by 90 degrees and the vertical position of the actuator 22 will change, as shown in
In one embodiment, the actuator and dial features have again been merged into a single part, now referred to only as the actuator. As before, rotation of the actuator, rather than the dial, allows for switching between breath-actuated nebulization and continuous nebulization. In order to reduce part count and create a design that eases the implementation of automated assembly, the dial was removed and the function incorporated into the actuator and the retainer. In order to switch the nebulizer between continuous nebulization and breath-actuated mode, a method of vertically positioning the actuator, and thus the distance between the baffle surface and the nozzle orifice, is incorporated onto the indicating surface of the actuator with receiving slots integrated into the retainer to hold the actuator in place when in use.
In this embodiment, the surface of the indicating portion of the actuator is designed with a raised ridge with sloping sides. The biasing element of the diaphragm, in addition to the force of the pressurized gas striking the diverter, push the actuator against protrusions found on the retainer and control the vertical positioning of the actuator. When the actuator is rotated such that the ridge move below the protrusions, the actuator is pushed to the down position and the baffle comes into contact with the nozzle jet stream and aerosol is produced. This embodiment allows for rotation in any direction with no radial orientation required on assembly. A flat protrusion from the top of the actuator is included as a feature by which to grip and rotate the actuator. The indicating surface of the actuator may also be manually depressed by pushing down with a finger to move the actuator to the nebulizing position. In another embodiment, the actuator and dial features have again been merged into a single part, now referred to only as the actuator.
As stated previously, rotation of the actuator, rather than the dial, allows for switching between breath-actuated nebulization and continuous nebulization. In order to switch the nebulizer between continuous nebulization and breath-actuated nebulization, a method of vertically positioning the actuator, and thus the distance between the diverter surface and the pressurized gas orifice, is incorporated onto the nozzle cover of the inner housing with protrusions on the actuator that follow the path of the ramp. In this embodiment the outer surface of the nozzle cover incorporates an overhanging ramp profile. The biasing element of the diaphragm, in addition to the force of the pressurized gas striking the diverter, pushes the protrusions located on the lower portion of the actuator against the ramp system and locates the vertical distance of the actuator. During assembly, the actuator snaps over the nozzle cover. A flat protrusion from the top of the actuator is included as a feature by which to grip and rotate the actuator, as in the embodiment of
The above embodiments of the nebulizer have been described for use in medical or therapeutic applications. It is noted that the principles of the invention disclosed herein may have applicability to other usages, such as industrial or manufacturing. It is intended that the foregoing detailed description be regarded as illustrative rather than limiting, and that it be understood that the following claims, including all equivalents, are intended to define the scope of this invention.
This application is a continuation of U.S. application Ser. No. 15/644,427 filed Jul. 7, 2017, pending, which claims the benefit of U.S. Provisional Application No. 62/360,165, filed Jul. 8, 2016, wherein the entire disclosure of each of the aforementioned applications is hereby incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1742740 | Watters | Jan 1930 | A |
2535844 | Emerson | Dec 1950 | A |
2882026 | Eichelman | Apr 1959 | A |
2951644 | Mahon et al. | Sep 1960 | A |
3001524 | Maison et al. | Sep 1961 | A |
3172406 | Bird et al. | Mar 1965 | A |
3269665 | Cheney | Aug 1966 | A |
3467092 | Bird et al. | Sep 1969 | A |
3490697 | Best, Jr. | Jan 1970 | A |
3580249 | Takaoka | May 1971 | A |
3584621 | Bird et al. | Jun 1971 | A |
3630196 | Bird et al. | Dec 1971 | A |
3658059 | Steil | Apr 1972 | A |
3664337 | Lindsey et al. | May 1972 | A |
3826255 | Havstad et al. | Jul 1974 | A |
3838686 | Szekely | Oct 1974 | A |
3874379 | Enfield et al. | Apr 1975 | A |
3903884 | Huston et al. | Sep 1975 | A |
3990442 | Patneau | Nov 1976 | A |
4093124 | Morane et al. | Jun 1978 | A |
4094317 | Wasnich | Jun 1978 | A |
4106503 | Rosenthal et al. | Aug 1978 | A |
4116387 | Kremer, Jr. et al. | Sep 1978 | A |
4139128 | Ewald | Feb 1979 | A |
4150071 | Pecina | Apr 1979 | A |
4181151 | Ensign | Jan 1980 | A |
4183361 | Russo | Jan 1980 | A |
4198969 | Virag | Apr 1980 | A |
4206644 | Platt | Jun 1980 | A |
4210140 | James et al. | Jul 1980 | A |
4210155 | Grimes | Jul 1980 | A |
4251033 | Rich et al. | Feb 1981 | A |
4253468 | Lehmbeck | Mar 1981 | A |
4268460 | Boiarski et al. | May 1981 | A |
4291688 | Kistler | Sep 1981 | A |
4333450 | Lester | Jun 1982 | A |
4413784 | Dea | Nov 1983 | A |
4452239 | Malem | Jun 1984 | A |
4456179 | Kremer | Jun 1984 | A |
4470412 | Nowacki et al. | Sep 1984 | A |
4484577 | Sackner et al. | Nov 1984 | A |
4508118 | Toth | Apr 1985 | A |
4509688 | Gagne et al. | Apr 1985 | A |
4588129 | Shanks | May 1986 | A |
4620670 | Hughes | Nov 1986 | A |
4622968 | Persson | Nov 1986 | A |
4627432 | Newell et al. | Dec 1986 | A |
4649911 | Knight | Mar 1987 | A |
4657007 | Carlin et al. | Apr 1987 | A |
4674491 | Brugger et al. | Jun 1987 | A |
4677975 | Edgar et al. | Jul 1987 | A |
4746067 | Svoboda | May 1988 | A |
4758224 | Siposs | Jul 1988 | A |
4792097 | Kremer, Jr. et al. | Dec 1988 | A |
4809692 | Nowacki et al. | Mar 1989 | A |
4832015 | Nowacki et al. | May 1989 | A |
4911157 | Miller | Mar 1990 | A |
4951659 | Weiler et al. | Aug 1990 | A |
4984158 | Hillsman | Jan 1991 | A |
5012803 | Foley et al. | May 1991 | A |
5012804 | Foley et al. | May 1991 | A |
5020527 | Dessertine | Jun 1991 | A |
5020530 | Miller | Jun 1991 | A |
5042467 | Foley | Aug 1991 | A |
5054477 | Terada et al. | Oct 1991 | A |
5054478 | Grychowski et al. | Oct 1991 | A |
5078131 | Foley | Jan 1992 | A |
5086765 | Levine | Feb 1992 | A |
5165392 | Small | Nov 1992 | A |
5167506 | Kilis et al. | Dec 1992 | A |
5170782 | Kocinski | Dec 1992 | A |
5209225 | Glenn | May 1993 | A |
5235969 | Bellm | Aug 1993 | A |
5241954 | Glenn | Sep 1993 | A |
5277175 | Riggs et al. | Jan 1994 | A |
5280784 | Kohler | Jan 1994 | A |
5299565 | Brown | Apr 1994 | A |
5301662 | Bagwell et al. | Apr 1994 | A |
5301663 | Small, Jr. | Apr 1994 | A |
5309900 | Knoch et al. | May 1994 | A |
5312046 | Knoch et al. | May 1994 | A |
5312281 | Takahashi et al. | May 1994 | A |
5318015 | Mansson et al. | Jun 1994 | A |
5333106 | Lanpher et al. | Jul 1994 | A |
5337926 | Drobish et al. | Aug 1994 | A |
5349947 | Newhouse et al. | Sep 1994 | A |
5363842 | Mishelevich et al. | Nov 1994 | A |
5383470 | Kolbly | Jan 1995 | A |
5385140 | Smith | Jan 1995 | A |
5392648 | Robertson | Feb 1995 | A |
5398714 | Price | Mar 1995 | A |
5427089 | Kraemer | Jun 1995 | A |
5431154 | Seigel et al. | Jul 1995 | A |
5458136 | Jaser et al. | Oct 1995 | A |
5461695 | Knoch | Oct 1995 | A |
5479920 | Piper et al. | Jan 1996 | A |
5487378 | Robertson et al. | Jan 1996 | A |
5497765 | Praud et al. | Mar 1996 | A |
5503139 | McMahon et al. | Apr 1996 | A |
5505192 | Samiotes et al. | Apr 1996 | A |
5505193 | Ballini et al. | Apr 1996 | A |
5511538 | Haber et al. | Apr 1996 | A |
5511539 | Lien | Apr 1996 | A |
5515842 | Ramseyer et al. | May 1996 | A |
5520166 | Ritson et al. | May 1996 | A |
5522380 | Dwork | Jun 1996 | A |
5533497 | Ryder | Jul 1996 | A |
5533501 | Denyer | Jul 1996 | A |
5544647 | Jewett et al. | Aug 1996 | A |
5549102 | Lintl et al. | Aug 1996 | A |
5570682 | Johnson | Nov 1996 | A |
5582162 | Petersson | Dec 1996 | A |
5584285 | Salter et al. | Dec 1996 | A |
5598839 | Niles et al. | Feb 1997 | A |
5601117 | Lewis | Feb 1997 | A |
5613489 | Miller et al. | Mar 1997 | A |
5617844 | King | Apr 1997 | A |
5622162 | Johansson et al. | Apr 1997 | A |
5630409 | Bono et al. | May 1997 | A |
5645049 | Foley et al. | Jul 1997 | A |
5687912 | Denyer | Nov 1997 | A |
5701886 | Ryatt | Dec 1997 | A |
5704344 | Cole | Jan 1998 | A |
5740793 | Hodson et al. | Apr 1998 | A |
5752505 | Ohki et al. | May 1998 | A |
5758638 | Kreamer | Jun 1998 | A |
5765553 | Richards et al. | Jun 1998 | A |
5792057 | Rubsamen et al. | Aug 1998 | A |
5803078 | Brauner | Sep 1998 | A |
5816240 | Komesaroff | Oct 1998 | A |
5823179 | Grychowski et al. | Oct 1998 | A |
5848588 | Foley et al. | Dec 1998 | A |
5865172 | Butler et al. | Feb 1999 | A |
5875774 | Clementi et al. | Mar 1999 | A |
5881718 | Mortensen et al. | Mar 1999 | A |
5899201 | Schultz et al. | May 1999 | A |
5937852 | Butler et al. | Aug 1999 | A |
5954049 | Foley et al. | Sep 1999 | A |
5988160 | Foley et al. | Nov 1999 | A |
6024120 | Yam | Feb 2000 | A |
6026807 | Puderbaugh et al. | Feb 2000 | A |
6039042 | Sladek | Mar 2000 | A |
6044841 | Verdun et al. | Apr 2000 | A |
6073628 | Butler et al. | Jun 2000 | A |
6116233 | Denyer et al. | Sep 2000 | A |
6116239 | Volgyesi | Sep 2000 | A |
6129080 | Pitcher et al. | Oct 2000 | A |
6131568 | Denyer et al. | Oct 2000 | A |
6176237 | Wunderlich et al. | Jan 2001 | B1 |
6179164 | Fuchs | Jan 2001 | B1 |
6223745 | Hammarlund et al. | May 2001 | B1 |
6237589 | Denyer et al. | May 2001 | B1 |
6253767 | Mantz | Jul 2001 | B1 |
6293279 | Schmidt et al. | Sep 2001 | B1 |
6338443 | Piper | Jan 2002 | B1 |
6345617 | Engelbreth et al. | Feb 2002 | B1 |
6435177 | Schmidt et al. | Aug 2002 | B1 |
6450163 | Blacker et al. | Sep 2002 | B1 |
6481435 | Hochrainer et al. | Nov 2002 | B2 |
6513519 | Gallem | Feb 2003 | B2 |
6543448 | Smith et al. | Apr 2003 | B1 |
6557549 | Schmidt et al. | May 2003 | B2 |
6578571 | Watt | Jun 2003 | B1 |
6584971 | Denyer et al. | Jul 2003 | B1 |
6595203 | Bird | Jul 2003 | B1 |
6606992 | Schuler et al. | Aug 2003 | B1 |
6612303 | Grychowski et al. | Sep 2003 | B1 |
6644304 | Grychowski et al. | Nov 2003 | B2 |
6679250 | Walker et al. | Jan 2004 | B2 |
6698421 | Attolini | Mar 2004 | B2 |
6708688 | Rubin et al. | Mar 2004 | B1 |
6748945 | Grychowski et al. | Jun 2004 | B2 |
6796513 | Fraccaroli | Sep 2004 | B2 |
6823862 | McNaughton | Nov 2004 | B2 |
6848443 | Schmidt et al. | Feb 2005 | B2 |
6857427 | Ziegler et al. | Feb 2005 | B2 |
6883517 | Halamish | Apr 2005 | B2 |
6885684 | Ichino | Apr 2005 | B2 |
6904908 | Bruce et al. | Jun 2005 | B2 |
6929003 | Blacker et al. | Aug 2005 | B2 |
6994083 | Foley et al. | Feb 2006 | B2 |
7013896 | Schmidt | Mar 2006 | B2 |
7036505 | Bacon et al. | May 2006 | B2 |
7051731 | Rogerson | May 2006 | B1 |
7080643 | Grychowski et al. | Jul 2006 | B2 |
7131439 | Blacker et al. | Nov 2006 | B2 |
7131440 | Sonntag | Nov 2006 | B2 |
7201165 | Bruce et al. | Apr 2007 | B2 |
7252085 | Kunschir | Aug 2007 | B2 |
7255106 | Gallem et al. | Aug 2007 | B2 |
7261102 | Barney et al. | Aug 2007 | B2 |
7267120 | Rustad et al. | Sep 2007 | B2 |
7270123 | Grychowski et al. | Sep 2007 | B2 |
7404400 | Lulla et al. | Jul 2008 | B2 |
RE40591 | Denyer | Dec 2008 | E |
7458372 | Feiner et al. | Dec 2008 | B2 |
7503843 | Wilmoth | Mar 2009 | B1 |
7559322 | Foley et al. | Jul 2009 | B2 |
7568480 | Foley et al. | Aug 2009 | B2 |
7581718 | Chang | Sep 2009 | B1 |
7634995 | Grychowski et al. | Dec 2009 | B2 |
7748385 | Lieberman et al. | Jul 2010 | B2 |
7758886 | Jauernig et al. | Jul 2010 | B2 |
7954487 | Grychowski et al. | Jun 2011 | B2 |
8113194 | Boehm et al. | Feb 2012 | B2 |
8333190 | Addington et al. | Dec 2012 | B2 |
8342171 | Boehm et al. | Jan 2013 | B2 |
8347878 | Schuschnig et al. | Jan 2013 | B2 |
8397712 | Foley et al. | Mar 2013 | B2 |
D680214 | Eckstein et al. | Apr 2013 | S |
8596264 | Sommer | Dec 2013 | B2 |
8844520 | Foley et al. | Sep 2014 | B2 |
9022023 | Korneff | May 2015 | B2 |
20020020762 | Selzer et al. | Feb 2002 | A1 |
20020104531 | Malone | Aug 2002 | A1 |
20020157663 | Blacker et al. | Oct 2002 | A1 |
20030089366 | Sommer | May 2003 | A1 |
20030136399 | Foley et al. | Jul 2003 | A1 |
20030159694 | McNaughton | Aug 2003 | A1 |
20030197068 | Abate | Oct 2003 | A1 |
20030209238 | Peters | Nov 2003 | A1 |
20050039741 | Gallem et al. | Feb 2005 | A1 |
20050145243 | Trombi | Jul 2005 | A1 |
20050183718 | Wuttke et al. | Aug 2005 | A1 |
20060011196 | Gallem et al. | Jan 2006 | A2 |
20060157052 | Foley et al. | Jul 2006 | A1 |
20070023036 | Grychowski et al. | Feb 2007 | A1 |
20070068513 | Kreutzmann et al. | Mar 2007 | A1 |
20070204864 | Grychowski et al. | Sep 2007 | A1 |
20070235028 | Bruce et al. | Oct 2007 | A1 |
20070289590 | Kreutzmann et al. | Dec 2007 | A1 |
20080083407 | Grychowski et al. | Apr 2008 | A1 |
20080230053 | Kraft | Sep 2008 | A1 |
20080257345 | Snyder et al. | Oct 2008 | A1 |
20090056716 | Carrier | Mar 2009 | A1 |
20090272820 | Foley et al. | Nov 2009 | A1 |
20110114090 | Piper | May 2011 | A1 |
20110137290 | Flickinger | Jun 2011 | A1 |
20110209700 | Kreutzmann et al. | Sep 2011 | A1 |
20120266872 | Tanaka et al. | Oct 2012 | A1 |
20120285447 | Schipper et al. | Nov 2012 | A1 |
20130037020 | Tanaka et al. | Feb 2013 | A1 |
20150231341 | Korneff | Aug 2015 | A1 |
Number | Date | Country |
---|---|---|
2996989 | Aug 1990 | AU |
2804852 | Aug 1978 | DE |
8703534 | Aug 1987 | DE |
199 02 847 | May 2000 | DE |
199 53 317 | Feb 2001 | DE |
0 261 649 | Sep 1987 | EP |
0 281 650 | Sep 1988 | EP |
0 414 536 | Feb 1991 | EP |
0 281 650 | Mar 1992 | EP |
0 514 085 | Nov 1992 | EP |
0 587 380 | Mar 1993 | EP |
0 601 708 | Jun 1994 | EP |
0 641 570 | Mar 1995 | EP |
0 711 609 | Jul 1995 | EP |
0 786 263 | Jan 1997 | EP |
0 855 224 | Jul 1998 | EP |
0 938 906 | Mar 1999 | EP |
0 855 224 | Jul 1999 | EP |
0 601 708 | Mar 2000 | EP |
1 439 875 | Oct 2002 | EP |
1 673 124 | Sep 2004 | EP |
2 548 599 | Feb 2011 | EP |
1 070 292 | Jul 1954 | FR |
93306974.2 | Mar 1993 | FR |
2 763 507 | Nov 1998 | FR |
497 530 | Dec 1939 | GB |
675524 | Jul 1952 | GB |
2 253 200 | Sep 1992 | GB |
2 299 512 | Oct 1996 | GB |
2 310 607 | Sep 1997 | GB |
8803419 | May 1988 | WO |
9009203 | Aug 1990 | WO |
WO 9215354 | Feb 1992 | WO |
9417753 | Aug 1994 | WO |
9826828 | Jun 1998 | WO |
9841265 | Sep 1998 | WO |
9844974 | Oct 1998 | WO |
9940959 | Aug 1999 | WO |
9953982 | Oct 1999 | WO |
0059565 | Oct 2000 | WO |
WO 2011135915 | Nov 2011 | WO |
WO 2011158715 | Dec 2011 | WO |
WO 2011158716 | Dec 2011 | WO |
WO 2013013852 A 1 | Jan 2013 | WO |
WO 2013099397 | Jul 2013 | WO |
WO 2013099398 | Jul 2013 | WO |
WO 2013099399 | Jul 2013 | WO |
WO 2014068387 | May 2014 | WO |
Entry |
---|
Product information excerpt, Boehringer Ingelheim, from web address: http://www.torpex.com/product_information/, Aug. 11, 2003 (4 pages). |
Product Information, Boerhinger Ingelheim, “Introducing TORPEX™ (aerosol albuteral sulfate): The Ultimate Tool for Equine Inhalation Treatment”, from website http://www.torpex.com/product_information/, Mar. 21, 2002, pp. 1-3 |
PARI LC Plus Instructions for Use (GB), PARI GmbH, dated Jul. 2001. |
Photographs of nebulizer manufactured by PARI GmbH with detachable gas flow interrupter believed to have been publicly available prior to Feb. 13, 1996. |
Number | Date | Country | |
---|---|---|---|
20210060270 A1 | Mar 2021 | US |
Number | Date | Country | |
---|---|---|---|
62360165 | Jul 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15644427 | Jul 2017 | US |
Child | 17016015 | US |